Pharmacokinetic Study of GB-5001A 280 mg Long Acting Injection, in Comparison With the Comparator Drug Aricept® 5 mg and Aricept® 10 mg Film-coated Tablet in Healthy Subjects

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study is to find out whether the bioavailability of GB‐5001A 280 mg Injection iscompared to the comparator drug of Aricept® 5 mg and Aricept® 10 mg which are Film‐CoatedTablet when administered in healthy subjects. Also to monitor the adverse events and toensure the safety of the subjects.
Epistemonikos ID: 5ab875c1d2ccae796a6dfdc58a02169a6d301e63
First added on: Sep 03, 2026